Sentiment-Signal
20,6
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Stammdaten
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.
Unternehmen & Branche
| Name | Unicycive Therapeutics, Inc. |
|---|---|
| Ticker | UNCY |
| CIK | 0001766140 |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | – |
| Marktkapitalisierung | 152,9 Mio. USD |
| Beta | 1,80 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | -26,555,000 | -1.67 | 49,135,000 | 30,197,000 | |
| 2025-09-30 | 10-Q | -6,011,000 | -0.33 | 50,611,000 | 37,480,000 | |
| 2025-06-30 | 10-Q | -6,447,000 | -0.52 | 29,995,000 | 16,429,000 | |
| 2025-03-31 | 10-Q | 570,000 | -0.05 | 27,947,000 | 11,271,000 | |
| 2024-12-31 | 10-K | -36,729,000 | -5.65 | 31,668,000 | 7,431,000 | |
| 2024-09-30 | 10-Q | -4,096,000 | -0.46 | 38,574,000 | -27,850,000 | |
| 2024-06-30 | 10-Q | 9,855,000 | -1.50 | 44,701,000 | -14,846,000 | |
| 2024-03-31 | 10-Q | -20,963,000 | -0.61 | 52,385,000 | -24,456,000 | |
| 2023-12-31 | 10-K | 675,000 | -30,544,000 | -1.28 | 14,191,000 | -3,809,000 |
| 2023-09-30 | 10-Q | 675,000 | -4,333,000 | -0.13 | 19,442,000 | 3,434,000 |
| 2023-06-30 | 10-Q | 675,000 | -3,838,000 | -0.29 | 22,883,000 | -19,372,000 |
| 2023-03-31 | 10-Q | 675,000 | -14,575,000 | -0.97 | 27,202,000 | -15,082,000 |
| 2022-12-31 | 10-K | 951,000 | -18,058,000 | -1.20 | 2,818,000 | -466,000 |
| 2022-09-30 | 10-Q | 951,000 | -5,557,000 | -0.37 | 10,177,000 | 4,626,000 |
| 2022-06-30 | 10-Q | -3,636,000 | -0.24 | 12,816,000 | 9,910,000 | |
| 2022-03-31 | 10-Q | -3,537,000 | -0.24 | 15,760,000 | 13,244,000 | |
| 2021-12-31 | 10-K | -10,017,000 | -0.86 | 18,744,000 | 16,484,000 | |
| 2021-09-30 | 10-Q | -5,201,000 | -0.37 | 19,782,000 | 18,997,000 | |
| 2021-06-30 | 10-Q | -1,100,000 | -0.13 | 913,000 | -4,202,000 | |
| 2021-03-31 | 10-Q | -964,000 | -0.11 | -3,402,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.